The importance of WDR5 in breast carcinomas has recently attracted increasing attention, mostly focusing on its cooperations with immunohistochemical markers such as ER and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.